- DNA Methylation
- Epigenetics
- Cancer Therapy
- +۳ مورد دیگر
Gregoire Rondelet is a researcher specializing in epigenetic cancer therapy, with a focus on DNA methyltransferases and their inhibition. He has collaborated extensively with J. Wouters and other colleagues on structural studies and drug development projects. Key affiliations include University of Liège (inferred from context) Active in structural biology, enzymology, and medicinal chemistry His research explores the molecular mechanisms of DNA methylation, histone interactions, and the design of non-nucleoside inhibitors for cancer treatment. Publications highlight collaborations with European institutions and contributions to structural biology databases. Scientific contributions include: Best Communication Prize at Séminaire des chercheurs Télévie (2015) Targeting DNA methylation for ATLL therapy (2015) His work spans high-impact areas such as cancer epigenetics, enzyme inhibition, and structure-based drug design, with research outputs cited over 197 times (h-index: 4). Activities include participation in international conferences and advanced training programs like the Vienna Summer School.











